Our data demonstrate for the first time that Hsp90 chaperone activity contributes to adverse outcomes in TDP-43 proteinopathies in vivo using a whole animal model of ALS. The gene discussed is HSP90AA1; the disease is amyotrophic lateral sclerosis.